Research output per year
Research output per year
Fingerprint
Dive into the research topics where Nethanel Asher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
DePalo, D. K., Dugan, M. M., Naqvi, S. M. H., Ollila, D. W., Hieken, T. J., Block, M. S., van Houdt, W. J., Wouters, M. W. J. M., Reijers, S. J. M., Asher, N., Broman, K. K., Duncan, Z., Anderson, M., Gyorki, D. E., Snow, H., Held, J., Farma, J. M., Vetto, J. T., Hui, J. Y. C. & Kolbow, M. & 10 others, , 1 Jan 2025, In: Cancer. 131, 1, e35636.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation
Averbuch, I., Edri, N., Asher, N., Markel, G., Hendler, D., Ditzian Kugler, H., Yosefof, E. & Kurman, N., Aug 2025, In: Cancer Immunology, Immunotherapy. 74, 8, 260.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
Grover, P., Lo, S. N., Li, I., Kuijpers, A. M. J., Kreidieh, F., Williamson, A., Amaral, T., Dimitriou, F., Placzke, J., Olino, K., Vitale, M. G., Saiag, P., Gutzmer, R., Allayous, C., Olofsson Bagge, R., Mattsson, J., Asher, N., Carter, T. J., Meniawy, T. M. & Lawless, A. R. & 48 others, , Jul 2025, In: Annals of Oncology. 36, 7, p. 807-818 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study
EUMelaReg Consortium Members, 2 May 2025, In: European Journal of Cancer. 220, 115339.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients
Yosefof, E., Edri, N., Ben-Nachum, I., Yaniv, D., Mizrachi, A., Asher, N., Ben-Dor, N., Ben-Artzi, A., Averbuch, I. & Kurman, N., 1 Feb 2025, In: Oncologist. 30, 2, oyaf022.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations